For instance, in breast cancer, it has been discovered that an MYC (proto-oncogene BHLH Transcription Factor; MYC) is a direct target of the FBXW7 protein, resulting in modifications of MYC protein levels and deregulation of a cell’s cycle [72]. This evidence concerns the gene MYC and breast carcinoma.